Home » PDUFA Clears Senate With Few Changes, House to Vote Next Week
PDUFA Clears Senate With Few Changes, House to Vote Next Week
The Senate overwhelmingly approved the omnibus FDA user fee bill 96–1 Thursday, rejecting a series of controversial amendments offered for vote on the floor. Senate leadership agreed to attach eight less-controversial drug-related amendments to the FDA Safety and Innovation Act, S. 3187, before it came to the floor. All eight amendments — including provisions to protect FDA whistleblowers and require an independent review of the agency’s drug review process — were adopted as part of the bill.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
07May
-
14May
-
30May